Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' FRUCHART JC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 324 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fruchart, JC
      Introducing a novel targeted approach to the treatment of hypercholesterolaemia: focus on the exogenous pathway - Proceedings of a satellite symposium held during the XXII Congress of the European Society of Cardiology, Amsterdam, The Netherlands, 26 August 2000 - Foreword

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    2. Fruchart, JC; Leitersdorf, E; Shepherd, J; Catapano, AL; Stein, E
      Cholesterol absorption inhibition: filling an unmet need in lipid-loweringmanagement - Discussion

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    3. Delerive, P; Monte, D; Dubois, G; Trottein, F; Fruchart-Najib, J; Mariani, J; Fruchart, JC; Staels, B
      The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response

      EMBO REPORTS
    4. Fruchart, JC
      PPAR and cardiovascular risk

      JOURNAL OF CARDIOVASCULAR RISK
    5. Duez, H; Fruchart, JC; Staels, B
      PPARs in inflammation, atherosclerosis and thrombosis

      JOURNAL OF CARDIOVASCULAR RISK
    6. Asset, G; Bauge, E; Fruchart, JC; Dallongeville, J
      Lack of triglyceride-lowering properties of fish oil in apolipoprotein E-deficient mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    7. Bard, JM; Charles, MA; Juhan-Vague, I; Vague, P; Andre, P; Safar, R; Fruchart, JC; Eschwege, E
      Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity - The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    8. Chinetti, G; Lestavel, S; Bocher, V; Remaley, AT; Neve, B; Torra, IP; Teissier, E; Minnich, A; Jaye, M; Duverger, N; Brewer, HB; Fruchart, JC; Clavey, V; Staels, B
      PPAR-alpha and PPAR-gamma activators induce cholesterol removal from humanmacrophage foam cells through stimulation of the ABCA1 pathway

      NATURE MEDICINE
    9. Fruchart, JC; Staels, B; Duriez, P
      PPARs, metabolic disease and atherosclerosis

      PHARMACOLOGICAL RESEARCH
    10. Torra, IP; Chinetti, G; Duval, C; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

      CURRENT OPINION IN LIPIDOLOGY
    11. Lestavel, S; Chinetti, G; Bocher, V; Fruchart, JC; Clavey, V; Staels, B
      Peroxisome proliferator-activated receptors in human atherosclerosis

      M S-MEDECINE SCIENCES
    12. Dallongeville, J; Meirhaeghe, A; Cottel, D; Fruchart, JC; Amouyel, P; Helbecque, N
      Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans

      INTERNATIONAL JOURNAL OF OBESITY
    13. Boullier, A; Hennuyer, N; Tailleux, A; Furman, C; Duverger, N; Caillaud, JM; Castro, G; Fievet, C; Fruchart, JC; Duriez, P
      Increased levels of high-density lipoprotein cholesterol are ineffective in inhibiting the development of immune responses to oxidized low-density lipoprotein and atherosclerosis in transgenic rabbits expressing human apolipoprotein (apo) A-1 with severe hypercholesterolaemia

      CLINICAL SCIENCE
    14. Pennacchio, LA; Olivier, M; Hubacek, JA; Cohen, JC; Cox, DR; Fruchart, JC; Krauss, RM; Rubin, EM
      An apolipoprotein influencing triglycerides in humans and mice revealed bycomparative sequencing

      SCIENCE
    15. Kandoussi, AM; Glowacki, F; Duriez, P; Tacquet, A; Fruchart, JC; Noel, C
      Evolution pattern of auto-antibodies against oxidized low-density lipoproteins in renal transplant recipients

      NEPHRON
    16. Quilliot, D; Walters, E; Guerci, B; Fruchart, JC; Duriez, P; Drouin, P; Ziegler, O
      Effect of the inflammation, chronic hyperglycemia, or malabsorption on theapolipoprotein A-IV concentration in type 1 diabetes mellitus and in diabetes secondary to chronic pancreatitis

      METABOLISM-CLINICAL AND EXPERIMENTAL
    17. Delerive, P; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptors in inflammation control

      JOURNAL OF ENDOCRINOLOGY
    18. Martin, G; Duez, H; Blanquart, C; Berezowski, V; Poulain, P; Fruchart, JC; Najib-Fruchart, J; Glineur, C; Staels, B
      Statin-induced inhibition of the Rho-signaling pathway activates PPAR alpha and induces HDL apoA-I

      JOURNAL OF CLINICAL INVESTIGATION
    19. Dallongeville, J; Bauge, E; Tailleux, A; Peters, JM; Gonzalez, FJ; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil

      JOURNAL OF BIOLOGICAL CHEMISTRY
    20. Raspe, E; Duez, H; Gervois, P; Fievet, C; Fruchart, JC; Besnard, S; Mariani, J; Tedgui, A; Staels, B
      Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor ROR alpha

      JOURNAL OF BIOLOGICAL CHEMISTRY
    21. Gervois, P; Vu-Dac, N; Kleemann, R; Kockx, M; Dubois, G; Laine, B; Kosykh, V; Fruchart, JC; Kooistra, T; Staels, B
      Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta

      JOURNAL OF BIOLOGICAL CHEMISTRY
    22. Bouly, M; Masson, D; Gross, B; Jiang, XC; Fievet, C; Castro, G; Tall, AR; Fruchart, JC; Staels, B; Lagrost, L; Luc, G
      Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate

      JOURNAL OF BIOLOGICAL CHEMISTRY
    23. Baroukh, N; Ostos, MA; Vergnes, L; Recalde, D; Staels, B; Fruchart, JC; Ochoa, A; Castro, G; Zakin, MM
      Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice reduces atherogenesis in response to a high fat-high cholesterol diet

      FEBS LETTERS
    24. Neve, BP; Corseaux, D; Chinetti, G; Zawadzki, C; Fruchart, JC; Duriez, P; Staels, B; Jude, B
      PPAR alpha agonists inhibit tissue factor expression in human monocytes and macrophages

      CIRCULATION
    25. Junquero, D; Pilon, A; Carilla-Durand, E; Patoiseau, JF; Tarayre, JP; Torpier, G; Staels, B; Fruchart, JC; Colpaert, FC; Clavey, V; Delhon, A
      Lack of toxic effects of F 12511, a novel potent inhibitor of acylcoenzymeA: cholesterol O-acyltransferase, on human adrenocortical cells in culture

      BIOCHEMICAL PHARMACOLOGY
    26. Fruchart, JC; Duriez, P
      Fundamental basis of atherosclerosis disease

      ANNALES D ENDOCRINOLOGIE
    27. Fruchart, JC; Staels, B; Duriez, P
      New conceptions in the mechanism of action of fibrates and prospective therapeutics in atherosclerosis

      BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE
    28. Tailleux, A; Labbe, J; Mallet, C; Percevault, F; Fruchart, JC; Fievet, C
      Measurement of rabbit apolipoprotein B by use of electroimmunodiffusion and immunonephelometric assays

      COMPARATIVE MEDICINE
    29. Fruchart, JC; Duriez, P
      Potential role of drug combinations in the prevention of cardiovascular disease

      EUROPEAN HEART JOURNAL SUPPLEMENTS
    30. Gervois, P; Torra, IP; Fruchart, JC; Staels, B
      Regulation of lipid and lipoprotein metabolism by PPAR activators

      CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    31. Pilon, A; Briand, O; Lestavel, S; Copin, C; Majd, Z; Fruchart, JC; Castro, G; Clavey, V
      Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    32. Desurmont, C; Caillaud, JM; Emmanuel, F; Benoit, P; Fruchart, JC; Castro, G; Branellec, D; Heard, JM; Duverger, N
      Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    33. Tailleux, A; Bouly, M; Luc, G; Castro, G; Caillaud, JM; Hennuyer, N; Poulain, P; Fruchart, JC; Duverger, N; Fievet, C
      Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    34. Vergnes, L; Baroukh, N; Ostos, MA; Castro, G; Duverger, N; Nanjee, MN; Najib, J; Fruchart, JC; Miller, NE; Zakin, MM; Ochoa, A
      Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    35. Zoete, V; Bailly, F; Vezin, H; Teissier, E; Duriez, P; Fruchart, JC; Catteau, JP; Bernier, JL
      4-Mercaptoimidazoles derived from the naturally occurring antioxidant ovothiols 1. Antioxidant properties

      FREE RADICAL RESEARCH
    36. Chinetti, G; Fruchart, JC; Staels, B
      Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation

      INFLAMMATION RESEARCH
    37. Lambert, M; Boullier, A; Hachulla, E; Fruchart, JC; Teissier, E; Hatron, PY; Duriez, P
      Paraoxonase activity is dramatically decreased in patients positive for anticardiolipin antibodies

      LUPUS
    38. Asset, G; Bauge, E; Wolff, RL; Fruchart, JC; Dallongeville, J
      Comparison of maritime pine oil and fish oil effects on plasma lipoproteins in apolipoprotein E-deficient mice

      PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
    39. Seidel, V; Verholle, M; Malard, Y; Tillequin, F; Fruchart, JC; Duriez, P; Bailleul, F; Teissier, E
      Phenylpropanoids from Ballota nigra L. inhibit in vitro LDL peroxidation

      PHYTOTHERAPY RESEARCH
    40. Martin, G; Nemoto, M; Gelman, L; Geffroy, S; Najib, J; Fruchart, JC; Roevens, P; de Martinville, B; Deeb, S; Auwerx, J
      The human fatty acid transport protein-1 (SLC27A1; FATP-1) cDNA and gene: Organization, chromosomal localization, and expression

      GENOMICS
    41. Fruchart, JC
      A need to redefine the consensus on the use of statins in coronary heart disease prevention

      EUROPEAN HEART JOURNAL
    42. Beghin, L; Duhal, N; Poulain, P; Hauw, P; Lacroix, B; Lecerf, JM; Bonte, JP; Fruchart, JC; Luc, G
      Measurement of apolipoprotein B concentration in plasma lipoproteins by combining selective precipitation and mass spectrometry

      JOURNAL OF LIPID RESEARCH
    43. Demeester, N; Castro, G; Desrumaux, C; De Geitere, C; Fruchart, JC; Santens, P; Mulleners, E; Engelborghs, S; De Deyn, PP; Vandekerckhove, J; Rosseneu, M; Labeur, C
      Characterization and functional studies of lipoproteins, lipid transfer proteins, and lecithin : cholesterol acyltransferase in CSF of normal individuals and patients with Alzheimer's disease

      JOURNAL OF LIPID RESEARCH
    44. Delerive, P; Gervois, P; Fruchart, JC; Staels, B
      Induction of I kappa B alpha expression as a mechanism contributing to theanti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators

      JOURNAL OF BIOLOGICAL CHEMISTRY
    45. Guerre-Millo, M; Gervois, P; Raspe, E; Madsen, L; Poulain, P; Derudas, B; Herbert, JM; Winegar, DA; Willson, TM; Fruchart, JC; Berge, RK; Staels, B
      Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    46. Martin, G; Poirier, H; Hennuyer, N; Crombie, D; Fruchart, JC; Heyman, RA; Besnard, P; Auwerx, J
      Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target

      JOURNAL OF BIOLOGICAL CHEMISTRY
    47. de Man, FHAF; de Beer, F; van der Laarse, A; Jansen, H; Leuven, JAG; Souverijn, JHM; Vroom, TFFP; Schoormans, SCM; Fruchart, JC; Havekes, LM; Smelt, AHM
      The hypolipidemic action of bezafibrate therapy in hypertriglyceridemia ismediated by upregulation of lipoprotein lipase: no effects on VLDL substrate affinity to lipolysis or LDL receptor binding

      ATHEROSCLEROSIS
    48. Adlouni, A; El Messal, M; Saile, R; Parra, HJ; Fruchart, JC; Ghalim, N
      Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles

      ATHEROSCLEROSIS
    49. Brites, FD; Bonavita, CD; De Geitere, C; Cloes, M; Delfly, B; Yael, MJ; Fruchart, JC; Wikinski, RW; Castgro, GR
      Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol levels

      ATHEROSCLEROSIS
    50. Dallongeville, J; Meirhaeghe, A; Cottel, D; Fruchart, JC; Amouyel, P; Helbecque, N
      Gender related association between genetic variations of APOC-III gene andlipid and lipoprotein variables in northern France

      ATHEROSCLEROSIS
    51. Perez-Mendez, O; Bruckert, E; Franceschini, G; Duhal, N; Lacroix, B; Bonte, JP; Sirtori, C; Fruchart, JC; Turpin, G; Luc, G
      Metabolism of apolipoproteins AI and AII in subjects carrying similar apoAI mutations, apoAI Milano and apoAI Paris

      ATHEROSCLEROSIS
    52. Delerive, P; Furman, C; Teissier, E; Fruchart, JC; Duriez, P; Staels, B
      Oxidized phospholipids activate PPAR alpha in a phospholipase A2-dependentmanner

      FEBS LETTERS
    53. Kee, F; Morrison, C; Poirier, O; McCrum, E; Mallet, C; Nicaud, V; McMaster, D; Dallongeville, J; Fruchart, JC; Evans, AE
      Angiotensin II type-I receptor and ACE polymorphisms and risk of myocardial infarction in men and women

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    54. Torra, IP; Tsibulsky, V; Delaunay, F; Saladin, R; Laudet, V; Fruchart, JC; Kosykh, V; Staels, B
      Circadian and glucocorticoid regulation of Rev-erb alpha expression in liver

      ENDOCRINOLOGY
    55. Boullier, A; Walters-Laporte, E; Hamon, M; Tailleux, A; Amant, C; Amouyel, P; Fruchart, JC; Bertrand, M; Duriez, P
      Absence of relationship between plasma Lp(a), Lp-AI, anti-oxidized LDL autoantibodies, LDL immune complexes concentrations and restenosis after percutaneous transluminal coronary angioplasty

      CLINICA CHIMICA ACTA
    56. Feillet, F; Feillet-Coudray, C; Bard, JM; Parra, HJ; Favre, E; Kabuth, B; Fruchart, JC; Vidailhet, M
      Plasma cholesterol and endogenous cholesterol synthesis during refeeding in anorexia nervosa

      CLINICA CHIMICA ACTA
    57. Chinetti, G; Gbaguidi, FG; Griglio, S; Mallat, Z; Antonucci, M; Poulain, P; Chapman, J; Fruchart, JC; Tedgui, A; Najib-Fruchart, J; Staels, B
      CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors

      CIRCULATION
    58. Asset, G; Leroy, A; Bauge, E; Wolff, RL; Fruchart, JC; Dallongeville, J
      Effects of dietary maritime pine (Pinus pinaster)-seed oil on high-densitylipoprotein levels and in vitro cholesterol efflux in mice expressing human apolipoprotein A-I

      BRITISH JOURNAL OF NUTRITION
    59. Neve, BP; Fruchart, JC; Staels, B
      Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis

      BIOCHEMICAL PHARMACOLOGY
    60. Mackness, M; Boullier, A; Hennuyer, N; Mackness, B; Hall, M; Tailleux, A; Duriez, P; Delfly, B; Durrington, P; Fruchart, JC; Duverger, N; Caillaud, JM; Castro, G
      Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits (vol 269, pg 232, 2000)

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    61. Mackness, N; Bouiller, A; Hennuyer, N; Mackness, B; Hall, M; Tailleux, A; Duriez, P; Delfly, B; Durrington, P; Fruchart, JC; Duverger, N; Caillaud, JM; Castro, G
      Paraoxonase activity is reduced by a pro-atherosclerotic diet in rabbits

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    62. Gelman, L; Fruchart, JC; Auwerx, J
      An update on the mechanisms of action of the peroxisome proliferator-activated receptors (PPARs) and their roles in inflammation and cancer

      CELLULAR AND MOLECULAR LIFE SCIENCES
    63. Andersson, Y; Majd, Z; Lefebvre, AM; Martin, G; Sechkin, AV; Kosykh, V; Fruchart, JC; Najib, J; Staels, B
      Developmental and pharmacological regulation of apolipoprotein C-II gene expression - Comparison with apo C-I and apo C-III gene regulation

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    64. Clavey, V; Copin, C; Mariotte, MC; Bauge, E; Chinetti, G; Fruchart, J; Fruchart, JC; Dallongeville, J; Staels, B
      Gels culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cells

      CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
    65. Fruchart, JC; Duriez, P; Staels, B
      Peroxisome proliferator-activated receptor-alpha activators regulate genesgoverning lipoprotein metabolism, vascular inflammation and atherosclerosis

      CURRENT OPINION IN LIPIDOLOGY
    66. Gozzo, A; Lesieur, D; Duriez, P; Fruchart, JC; Teissier, E
      Structure-activity relationships in a series of melatonin analogues with the low-density lipoprotein oxidation model

      FREE RADICAL BIOLOGY AND MEDICINE
    67. Gervois, P; Torra, IP; Chinetti, G; Grotzinger, T; Dubois, G; Fruchart, JC; Fruchart-Najib, J; Leitersdorf, E; Staels, B
      A truncated human peroxisome proliferator-activated receptor alpha splice variant with dominant negative activity

      MOLECULAR ENDOCRINOLOGY
    68. Gervois, P; Chopin-Delannoy, S; Fadel, A; Dubois, G; Kosykh, V; Fruchart, JC; Najib, J; Laudet, V; Staels, B
      Fibrates increase human REV-ERB alpha expression in liver via a novel peroxisome proliferator-activated receptor response element

      MOLECULAR ENDOCRINOLOGY
    69. Brendel, C; Fruchart, JC; Auwerx, J; Schoonjans, K
      Transcriptional regulation of cholesterol metabolism

      M S-MEDECINE SCIENCES
    70. Ulloa, N; Bustos, P; Castro, G; Fruchart, J; Vera, M; Fruchart, JC; Calvo, C
      Characterization of monoclonal antibodies against apolipoproteins A-I and A-II. Epitope expression in LpA-I and LpA-I : A-II particles

      HYBRIDOMA
    71. Fajas, L; Schoonjans, K; Gelman, L; Kim, JB; Najib, J; Martin, G; Fruchart, JC; Briggs, M; Spiegelman, BM; Auwerx, J
      Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1. Implications for adipocyte differentiation and metabolism

      MOLECULAR AND CELLULAR BIOLOGY
    72. Romon, M; Lebel, P; Velly, C; Marecaux, N; Fruchart, JC; Dallongeville, J
      Leptin response to carbohydrate or fat meal and association with subsequent satiety and energy intake

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    73. Asset, G; Staels, B; Wolff, RL; Bauge, E; Madj, Z; Fruchart, JC; Dallongeville, J
      Effects of Pinus pinaster and Pinus koraiensis seed oil supplementation onlipoprotein metabolism in the rat

      LIPIDS
    74. Raspe, E; Madsen, L; Lefebvre, AM; Leitersdorf, I; Gelman, L; Peinado-Onsurbe, J; Dallongeville, J; Fruchart, JC; Berge, R; Staels, B
      Modulation of rat liver apolipoprotein gene expression and serum lipid levels by tetradecylthioacetic acid (TTA) via PPAR alpha activation

      JOURNAL OF LIPID RESEARCH
    75. Lefebvre, AM; Paulweber, B; Fajas, L; Woods, J; McCrary, C; Colombel, JF; Najib, J; Fruchart, JC; Datz, C; Vidal, H; Desreumaux, P; Auwerx, J
      Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells

      JOURNAL OF ENDOCRINOLOGY
    76. Delerive, P; De Bosscher, K; Besnard, S; Vanden Berghe, W; Peters, JM; Gonzalez, FJ; Fruchart, JC; Tedgui, A; Haegeman, G; Staels, B
      Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappa B and AP-1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    77. Gelman, L; Zhou, GC; Fajas, L; Raspe, E; Fruchart, JC; Auwerx, J
      p300 interacts with the N- and C-terminal part of PPAR gamma 2 in a ligand-independent and -dependent manner, respectively

      JOURNAL OF BIOLOGICAL CHEMISTRY
    78. Fruchart, JC
      HDL subclasses impact of metabolic and therapeutic interventions

      ATHEROSCLEROSIS
    79. Kee, F; Amouyel, P; Fumeron, F; Arveiler, D; Cambou, JP; Evans, A; Cambien, F; Fruchart, JC; Ducimetiere, P; Dallongeville, J
      Lack of association between genetic variations of apo A-I-C-III-A-IV gene cluster and myocardial infarction in a sample of European male: ECTIM study

      ATHEROSCLEROSIS
    80. Schoonjans, K; Peinado-Onsurbe, J; Fruchart, JC; Tailleux, A; Fievet, C; Auwerx, J
      3-hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase

      FEBS LETTERS
    81. Gottrand, F; Beghin, L; Duhal, N; Lacroix, B; Bonte, JP; Fruchart, JC; Luc, G
      Moderate red wine consumption in healthy volunteers reduced plasma clearance of apolipoprotein AII

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    82. Ginzinger, DG; Clee, SM; Dallongeville, J; Lewis, MES; Henderson, HE; Bauje, E; Rogers, QR; Jensen, DR; Eckel, RH; Dyer, R; Innis, S; Jones, B; Fruchart, JC; Hayden, MR
      Lipid and lipoprotein analysis of cats with lipoprotein lipase deficiency

      EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    83. Martin, G; Pilon, A; Albert, C; Valle, M; Hum, DW; Fruchart, JC; Najib, J; Clavey, V; Staels, B
      Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cells

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    84. Duriez, P; Fruchart, JC
      High-density lipoprotein subclasses and apolipoprotein A-I

      CLINICA CHIMICA ACTA
    85. Brites, FD; Cavallero, E; de Geitere, C; Nicolaiew, N; Jacotot, B; Rosseneu, M; Fruchart, JC; Wikinski, RL; Castro, GR
      Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients

      CLINICA CHIMICA ACTA
    86. Delerive, P; Martin-Nizard, F; Chinetti, G; Trottein, F; Fruchart, JC; Najib, J; Duriez, P; Staels, B
      Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

      CIRCULATION RESEARCH
    87. Hennuyer, N; Poulain, P; Madsen, L; Berge, RK; Houdebine, LM; Branellec, D; Fruchart, JC; Fievet, C; Duverger, N; Staels, B
      Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response

      CIRCULATION
    88. Benoit, P; Emmanuel, F; Caillaud, JM; Bassinet, L; Castro, G; Gallix, P; Fruchart, JC; Branellec, D; Denefle, P; Duverger, N
      Somatic gene transfer of human apoA-I inhibits atherosclerosis progressionin mouse models

      CIRCULATION
    89. Assmann, G; Carmena, R; Cullen, P; Fruchart, JC; Jossa, F; Lewis, B; Mancini, M; Paoletti, R
      Coronary heart disease: Reducing the risk - A worldwide view

      CIRCULATION
    90. Fruchart, JC; Duriez, P
      Genes, dyslipoproteinemias and atherosclerosis: from the experimental approach to therapeutics

      ANNALES D ENDOCRINOLOGIE
    91. Le Fur, C; Romon, M; Lebel, P; Devos, P; Lancry, A; Guedon-Moreau, L; Fruchart, JC; Dallongeville, J
      Influence of mental stress and circadian cycle on pastprandial lipemia

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    92. LEFEBVRE AM; CHEN IH; DESREUMAUX P; NAJIB J; FRUCHART JC; GEBOES K; BRIGGS M; HEYMAN R; AUWERX J
      ACTIVATION OF THE PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA PROMOTES THE DEVELOPMENT OF COLON TUMORS IN C57BL 6J-APC(MIN)/+ MICE/

      Nature medicine
    93. FAJAS L; FRUCHART JC; AUWERX J
      TRANSCRIPTIONAL CONTROL OF ADIPOGENESIS

      Current opinion in cell biology
    94. FERRIERES J; EVANS A; AMOUYEL P; ARVEILER D; YARNELL J; RUIDAVETS JB; VAGUE IJ; FRUCHART JC; LUC G; SCARABIN PY; CAMBIEN F; DUCIMETIERE P
      RISK-FACTORS IN 2 POPULATIONS AT CONTRASTING RISK FOR CORONARY-ARTERYDISEASE

      Journal of the American College of Cardiology
    95. DALLONGEVILLE J; HECQUET B; LEBEL P; EDME JL; LEFUR C; FRUCHART JC; AUWERX J; ROMON M
      SHORT-TERM RESPONSE OF CIRCULATING LEPTIN TO FEEDING AND FASTING IN MAN - INFLUENCE OF CIRCADIAN CYCLE

      International journal of obesity
    96. FRUCHART JC; DURIEZ P
      HIGH-DENSITY-LIPOPROTEINS AND CORONARY HEART-DISEASE - FUTURE-PROSPECTS IN GENE-THERAPY

      Biochimie
    97. DALLONGEVILLE J; FRUCHART JC
      POSTPRANDIAL DYSLIPIDEMIA - A RISK FACTOR FOR CORONARY HEART-DISEASE

      Annals of nutrition & metabolism
    98. WALTERSLAPORTE E; FURMAN C; FOUQUET S; MARTINNIZARD F; LESTAVEL S; GOZZO A; LESIEUR D; FRUCHART JC; DURIEZ P; TEISSIER E
      A HIGH-CONCENTRATION OF MELATONIN INHIBITS IN-VITRO LDL PEROXIDATION BUT NOT OXIDIZED LDL TOXICITY TOWARD CULTURED ENDOTHELIAL-CELLS

      Journal of cardiovascular pharmacology
    99. STAELS B; KOENIG W; HABIB A; MERVAL R; LEBRET M; TORRA IP; DELERIVE P; FADEL A; CHINETTI G; FRUCHART JC; NAJIB J; MACLOUF J; TEDGUI A
      ACTIVATION OF HUMAN AORTIC SMOOTH-MUSCLE CELLS IS INHIBITED BY PPAR-ALPHA BUT NOT BY PPAR-GAMMA ACTIVATORS

      Nature
    100. DALLONGEVILLE J; MARECAUX N; FRUCHART JC; AMOUYEL P
      CIGARETTE-SMOKING IS ASSOCIATED WITH UNHEALTHY PATTERNS OF NUTRIENT INTAKE - A METAANALYSIS

      The Journal of nutrition


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 19:26:54